Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
0.9342
+0.0482 (5.44%)
Oct 1, 2026, 3:37 PM EDT - Market open
Filana Therapeutics Employees
As of December 31, 2025, Filana Therapeutics had 20 total employees, including 17 full-time and 3 part-time employees. The number of employees decreased by 10 or -33.33% compared to the previous year.
Employees
20
Change (1Y)
-10
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,114,000
Market Cap
45.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 20 | -10 | -33.33% | 17 | 3 |
| Dec 31, 2024 | 30 | 1 | 3.45% | 30 | 0 |
| Dec 31, 2023 | 29 | 3 | 11.54% | 29 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 26 | 0 |
| Dec 31, 2021 | 24 | 13 | 118.18% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Metagenomi Therapeutics | 113 |
| Elicio Therapeutics | 33 |
| PDS Biotechnology | 21 |
| Veru Inc. | 20 |
| CervoMed | 15 |
| Werewolf Therapeutics | 14 |
| Dogwood Therapeutics | 8 |
FLNA News
- 9 days ago - Filana can proceed with study as hold lifted, says Lucid Capital - TheFly
- 9 days ago - Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam - TheFly
- 9 days ago - Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy - GlobeNewsWire
- 7 weeks ago - Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 2 months ago - Filana Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Filana Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Filana Therapeutics Slides: Corporate presentation - Filings